{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:10:14Z","timestamp":1787793014350,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1038\/s41434-021-00278-2","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T21:03:10Z","timestamp":1629234190000},"page":"322-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characterization of integration frequency and insertion sites of adenovirus DNA into mouse liver genomic DNA following intravenous injection"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8037-0375","authenticated-orcid":false,"given":"Zhibin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Troilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Thomas G.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laural B.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B.","family":"Barnum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Pacchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy J.","family":"Pauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Lebron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2837-8262","authenticated-orcid":false,"given":"Jayanthi","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Ledwith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"278_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1054-3589(08)60140-4","volume":"40","author":"MM Hitt","year":"1997","unstructured":"Hitt MM, Addison CL, Graham FL. Human adenovirus vectors for gene transfer into mammalian cells. Adv Pharmacol. 1997;40:137\u2013206.","journal-title":"Adv Pharmacol."},{"key":"278_CR2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1089\/104454902762053855","volume":"21","author":"CM Lai","year":"2002","unstructured":"Lai CM, Lai YK, Rakoczy PE. Adenovirus and adeno-associated virus vectors. DNA Cell Biol. 2002;21:895\u2013913.","journal-title":"DNA Cell Biol"},{"key":"278_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.gt.3302071","volume":"10","author":"JA St George","year":"2003","unstructured":"St George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther. 2003;10:1135\u201341.","journal-title":"Gene Ther"},{"key":"278_CR4","doi-asserted-by":"publisher","first-page":"e3015","DOI":"10.1002\/jgm.3015.","volume":"20","author":"SL Ginn","year":"2018","unstructured":"Ginn SL, Anais K, Amaya AK, Ian E, Alexander IE, Edelstein M, et al. Gene therapy clinical trials worldwide to 2017: an update. J Gene Med. 2018;20:e3015. https:\/\/doi.org\/10.1002\/jgm.3015.","journal-title":"J Gene Med"},{"key":"278_CR5","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1073\/pnas.95.14.7866","volume":"95","author":"MA Morsy","year":"1998","unstructured":"Morsy MA, Gu M, Motzel S, Zhao J, Jing Lin J, Su Q, et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci USA. 1998;95:7866\u201371.","journal-title":"Proc Natl Acad Sci USA."},{"key":"278_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.gt.3300565","volume":"5","author":"MA Morsy","year":"1998","unstructured":"Morsy MA, Gu MC, Zhao JZ, Holder DJ, Rogers IT, Pouch WJ, et al. Leptin gene therapy and daily protein administration: a comparative study in the ob\/ob mouse. Gene Ther. 1998;5:8\u201318.","journal-title":"Gene Ther"},{"key":"278_CR7","unstructured":"European Medicines Agency. Expert Committee on Medicinal Products Gene Therapy. Report from the CPMP Gene Therapy Expert Group Meeting 26th-27th February 2004. EMEA\/CPMP\/1879\/04\/Final."},{"key":"278_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1566523024605591","volume":"2","author":"K Mitani","year":"2002","unstructured":"Mitani K, Kubo S. Adenovirus as an integrating vector. Curr Gene Ther. 2002;2:135\u201344.","journal-title":"Curr Gene Ther."},{"key":"278_CR9","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1128\/JVI.73.7.6141-6146.1999","volume":"73","author":"A Harui","year":"1999","unstructured":"Harui A, Suzuki S, Kochanek S, Mitani K. Frequency and stability of chromosomal integration of adenovirus vectors. J Virol. 1999;73:6141\u20136.","journal-title":"J Virol."},{"key":"278_CR10","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1128\/JVI.75.20.9896-9908.2001","volume":"75","author":"M Hillgenberg","year":"2001","unstructured":"Hillgenberg M, Tonnies H, Strauss M. Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer. J Virol. 2001;75:9896\u2013908.","journal-title":"J Virol."},{"key":"278_CR11","first-page":"F79","volume":"1288","author":"W Doerfler","year":"1996","unstructured":"Doerfler W. A new concept in (adenoviral) oncogenesis: integration of foreign DNA and its consequences. Biochim Biophys Acta. 1996;1288:F79\u2013F99.","journal-title":"Biochim Biophys Acta."},{"key":"278_CR12","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/jgm.1246","volume":"10","author":"SL Stephen","year":"2008","unstructured":"Stephen SL, Sivanandam VG, Kochanek S. Homologous and heterologous recombination between adenovirus vector DNA and chromosomal DNA. J Gene Med. 2008;10:1176\u201389.","journal-title":"J Gene Med"},{"key":"278_CR13","first-page":"3001","volume":"57","author":"K Hilger-Eversheim","year":"1997","unstructured":"Hilger-Eversheim K, Doerfler W. Clonal origin of adenovirus type 12-induced hamster tumors: nonspecific chromosomal integration sites of viral DNA. Cancer Res. 1997;57:3001\u20139.","journal-title":"Cancer Res"},{"key":"278_CR14","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.1128\/JVI.00751-10","volume":"84","author":"SL Stephen","year":"2010","unstructured":"Stephen SL, Montini E, Sivanandam VG, Al-Dhalimy M, Kestler HA, Finegold M, et al. Chromosomal integration of adenoviral vector DNA in vivo. J Virol. 2010;84:9987\u201394.","journal-title":"J Virol"},{"key":"278_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1749-6632.1995.tb44729.x","volume":"772","author":"WW Nichols","year":"1995","unstructured":"Nichols WW, Ledwith BJ, Manam SV, Troilo PJ. Potential DNA vaccine integration into host cell genome. Ann N Y Acad Sci. 1995;772:30\u201339.","journal-title":"Ann N Y Acad Sci."},{"key":"278_CR16","first-page":"33","volume":"104","author":"BJ Ledwith","year":"2000","unstructured":"Ledwith BJ, Manam S, Troilo PJ, Barnum AB, Pauley CJ, Griffiths TG II, et al. Plasmid DNA vaccines: assay for integration into host genomic DNA. Dev Biol (Basel). 2000;104:33\u201343.","journal-title":"Dev Biol (Basel)"},{"key":"278_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000053993","volume":"43","author":"BJ Ledwith","year":"2000","unstructured":"Ledwith BJ, Manam S, Troilo PJ, Barnum AB, Pauley CJ, Griffiths TG II, et al. Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice. Intervirology. 2000;43:258\u201372.","journal-title":"Intervirology."},{"key":"278_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.gt.3302213","volume":"11","author":"Z Wang","year":"2004","unstructured":"Wang Z, Troilo PJ, Wang X, Griffiths TG II, Pacchione SJ, Barnum AB, et al. Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Ther. 2004;11:711\u201321.","journal-title":"Gene Ther"},{"key":"278_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nature01262","volume":"420","author":"RH Waterston","year":"2002","unstructured":"Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, et al. Initial sequencing and comparative analysis of the mouse genome. Nature. 2002;420:520\u201362.","journal-title":"Nature."},{"key":"278_CR20","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.gt.3302036","volume":"10","author":"Q Liu","year":"2003","unstructured":"Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 2003;10:935\u201340.","journal-title":"Gene Ther"},{"key":"278_CR21","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1182\/blood-2010-08-302729","volume":"117","author":"H Li","year":"2011","unstructured":"Li H, Malani N, Hamilton SR, Schlachterman A, Bussadori G, Edmonson SE, et al. Assessing the potential for AAV vector genotoxicity in a murine model. Blood. 2011;117:3311\u20139.","journal-title":"Blood."},{"key":"278_CR22","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/mt.2012.47","volume":"20","author":"A Nowrouzi","year":"2012","unstructured":"Nowrouzi A, Penaud-Budloo M, Kaeppel C, Appelt U, Guiner CL, Moullier P, et al. Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver. Mol Ther. 2012;20:1177\u201386.","journal-title":"Mol Ther."},{"key":"278_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nm.3230","volume":"19","author":"C Kaeppel","year":"2013","unstructured":"Kaeppel C, Beattie SG, Fronza R, Logtenstein RV, Salmon F, Schmidt S, et al. A largely random AAV integration profile after LPLD gene therapy. Nat Med. 2013;19:889.","journal-title":"Nat Med."},{"key":"278_CR24","doi-asserted-by":"crossref","unstructured":"Milholland B, Dong X, Zhang L, Hao X, Suh Y, Vijg JJ. Differences between germline and somatic mutation rates in humans and mice. Nat Commun. 2017;8:15183.","DOI":"10.1038\/ncomms15183"},{"key":"278_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0027-5107(94)90320-4","volume":"304","author":"J Cole","year":"1994","unstructured":"Cole J, Skopek TR. International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 3. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat Res. 1994;304:33\u2013105.","journal-title":"Mutat Res."},{"key":"278_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/d41586-018-05462-w","volume":"558","author":"C Willyard","year":"2018","unstructured":"Willyard C. New human gene tally reignites debate. Nature. 2018;558:354\u20135.","journal-title":"Nature"},{"key":"278_CR27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/sj.gt.3302074","volume":"10","author":"H Wurtele","year":"2003","unstructured":"Wurtele H, Little KC, Chartrand P. Illegitimate DNA integration in mammalian cells. Gene Ther. 2003;10:1791\u20139.","journal-title":"Gene Ther"},{"key":"278_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ng1179","volume":"34","author":"H Nakai","year":"2003","unstructured":"Nakai H, Montini E, Fuess S, Storm TA, Grompe M, Kay MA. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat Genet. 2003;34:297\u2013302.","journal-title":"Nat Genet."},{"key":"278_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","volume":"110","author":"AR Schroder","year":"2002","unstructured":"Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521\u20139.","journal-title":"Cell."},{"key":"278_CR30","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.1083413","volume":"300","author":"X Wu","year":"2003","unstructured":"Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science. 2003;300:1749\u201351.","journal-title":"Science."},{"key":"278_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMra032207","volume":"350","author":"MP McCormack","year":"2004","unstructured":"McCormack MP, Rabbitts TH. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2004;350:913\u201322.","journal-title":"N Engl J Med."},{"key":"278_CR32","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1126\/science.307.5715.1544a","volume":"307","author":"J Kaiser","year":"2005","unstructured":"Kaiser J. Gene therapy. Panel urges limits on X-SCID trials. Science. 2005;307:1544\u20135.","journal-title":"Science."},{"key":"278_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/jgm.466","volume":"6","author":"Insertional mutagenesis and oncogenesis: update from non-clinical and clinical studies.","year":"2004","unstructured":"Insertional mutagenesis and oncogenesis: update from non-clinical and clinical studies. Gene Therapy Expert Group of the Committee for Proprietary Medical Products (CPMP), European Agency for the Evaluation of Medical Products - June 2003 meeting. J Gene Med. 2004;6:127\u20139.","journal-title":"J Gene Med"},{"key":"278_CR34","first-page":"29","volume":"123","author":"K Cichutek","year":"2006","unstructured":"Cichutek K. Lessons learned from gene therapy concerning and the use of integrating vectors and the possible risk of insertional oncogenesis. Dev Biol (Basel). 2006;123:29\u201334.","journal-title":"Dev Biol (Basel)"},{"key":"278_CR35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/hum.2017.009","volume":"28","author":"RJ Chandler","year":"2017","unstructured":"Chandler RJ, Sands MS, Venditti CP. Recombinant adeno-associated viral integration and genotoxicity: insights from animal models. Human Gene Ther. 2017;28:314\u201322.","journal-title":"Human Gene Ther."},{"key":"278_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","volume":"39","author":"GN Nguyen","year":"2021","unstructured":"Nguyen GN, Everett JK, Kafle S, Roche AM, Raymond HE, Leiby J. A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells. Nat Biotech. 2021;39:47\u201355.","journal-title":"Nat Biotech."},{"key":"278_CR37","first-page":"251","volume":"123","author":"BJ Ledwith","year":"2006","unstructured":"Ledwith BJ, Lanning CL, Gumprecht LA, Anderson CA, Coleman JB, Gatto NT, et al. Tumorigenicity assessments of Per.C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line. Dev Biol (Basel). 2006;123:251\u201363.","journal-title":"Dev Biol (Basel)"},{"key":"278_CR38","unstructured":"WHO. Meeting Report. WHO informal consultation on characterization and quality aspect of vaccines based on live viral vectors. Geneva: World Health Organization; 2003. pp. 9\u201310."}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00278-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00278-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00278-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T19:03:05Z","timestamp":1655406185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00278-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1038\/s41434-021-00278-2","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"assertion":[{"value":"30 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}